Literature DB >> 3192546

Interaction of the Mr = 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor.

M Denis1, J A Gustafsson, A C Wikström.   

Abstract

We have investigated the physiochemical characteristics of trypsin-treated, molybdate-stabilized glucocorticoid-receptor complexes from rat liver in the presence of 10 mM sodium molybdate by high performance ion-exchange chromatography, high performance size-exclusion chromatography, and sedimentation analysis. Trypsin treatment was performed under conditions previously reported to degrade the monomeric Mr approximately 94,000 steroid-binding protein to an Mr approximately 27,000 ligand-binding entity (Wrange, O., and Gustafsson, J.-A. (1978) J. Biol. Chem. 253, 856-865). Also in the presence of molybdate, an Mr approximately 27,000 steroid-binding fragment was obtained by limited trypsinization. However, no major differences in the tested physicochemical parameters were seen when trypsin-treated glucocorticoid-receptor complexes were compared with crude cytosolic complexes. Furthermore, the Mr approximately 27,000 steroid-binding fragment generated in the presence of molybdate could be immunoprecipitated by antibodies specific for the glucocorticoid receptor-associated Mr approximately 90,000 heat shock protein. These results provide direct evidence for an interaction of the Mr approximately 90,000 heat shock protein with the steroid-binding domain of the glucocorticoid receptor, known to correspond to the C-terminal third of the receptor protein.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3192546

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Aldosterone antagonists destabilize the mineralocorticosteroid receptor.

Authors:  B Couette; M Lombes; E E Baulieu; M E Rafestin-Oblin
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

2.  Signal transduction by steroid hormones: nuclear localization is differentially regulated in estrogen and glucocorticoid receptors.

Authors:  D Picard; V Kumar; P Chambon; K R Yamamoto
Journal:  Cell Regul       Date:  1990-02

Review 3.  Glucocorticoid receptor: implications for rheumatic diseases.

Authors:  T Kino; E Charmandari; G P Chrousos
Journal:  Clin Exp Rheumatol       Date:  2011-10-21       Impact factor: 4.473

4.  Arachidonic acid metabolism in heat-shock treated human leucocytes.

Authors:  M Köller; W König
Journal:  Immunology       Date:  1990-08       Impact factor: 7.397

5.  Distinct functions of the 90 kDa heat-shock protein (hsp90) in oestrogen and mineralocorticosteroid receptor activity: effects of hsp90 deletion mutants.

Authors:  N Binart; M Lombès; E E Baulieu
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

6.  Interaction of glucocorticosteroid receptor and wild-type or mutated 90-kDa heat shock protein coexpressed in baculovirus-infected Sf9 cells.

Authors:  F Cadepond; N Binart; B Chambraud; N Jibard; G Schweizer-Groyer; I Segard-Maurel; E E Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-15       Impact factor: 11.205

7.  Transformation of the aryl hydrocarbon receptor to a DNA-binding form is accompanied by release of the 90 kDa heat-shock protein and increased affinity for 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  E C Henry; T A Gasiewicz
Journal:  Biochem J       Date:  1993-08-15       Impact factor: 3.857

8.  In situ distinction between steroid receptor binding and transactivation at a target gene.

Authors:  D P McDonnell; Z Nawaz; B W O'Malley
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

Review 9.  A role for glucocorticoids in stress-impaired reproduction: beyond the hypothalamus and pituitary.

Authors:  Shannon Whirledge; John A Cidlowski
Journal:  Endocrinology       Date:  2013-09-24       Impact factor: 4.736

Review 10.  Molecular chaperones in pathogen virulence: emerging new targets for therapy.

Authors:  Len Neckers; Utpal Tatu
Journal:  Cell Host Microbe       Date:  2008-12-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.